Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Data Byte

Translational spotlight on East-West innovation 

Collaborations between investigators at Asian and Western universities in BioCentury’s Distillery present licensing and partnering opportunities

By Karen Tkach Tuzman, Senior Editor
November 23, 2022 1:29 AM UTC

Preclinical innovations from cross-border teams captured in BioCentury’s Distillery include a PUS7-inhibiting compound for glioblastoma, a NOD2-activating bacterial enzyme for colitis, and a natural product-based, non-hormonal male contraceptive.

BioCentury’s Distillery, a curated collection of translational studies from more than 25 journals, provides brief summaries of preclinical papers that showcase targets and technologies with disease-modifying effects...

Get Unlimited Access
Continue reading with a free trial.
Start a Free TrialLog In
Or Purchase This Article

BCIQ Company Profiles

Beckman Research Institute of City of Hope

Brigham and Women's Hospital

Chinese University of Hong Kong

Fujian Medical University

Haimbio Ltd.

National Center for Nanoscience and Technology

National Health Commission of the People's Republic of China